Usage: The invention relates to medicine, particularly to children allergo- ogy, and can be used in clinical practice as an objective evaluation criteria specific immunotherapy. The goal - reducing trauma. The inventive method consists in a parallel formulation prick tests with allergens following concentrations: 10000, 5000, 2500, 1250, 625, mixed with equal amounts of patient sera taken before and after that specific immunotherapy. Is determined by increasing the ratio of blocking antibodies (Kubat) according to the formula R Kubat / DP - the minimum concentration of allergen at which a positive reaction in skarifikatsionnye - mixture with serum taken after that treatment. D-allergen minimum concentration at which a positive prick reaction in admixture with serum taken that before treatment. Positive effect . - reduction of traumatism. g
展开▼
机译：用途：本发明涉及医学，特别是涉及儿童过敏学，并且可以在临床实践中用作特异性免疫疗法的客观评价标准。目标-减少创伤。本发明的方法包括用以下浓度的变应原进行平行制剂的点刺试验：10000、5000、2500、1250、625，在该特异性免疫治疗之前和之后与等量的患者血清混合。通过根据公式R Kubat / DP增加封闭性抗体（Kubat）的比率来确定-skarifikatsionnye中发生阳性反应的最小变应原浓度-处理后与血清的混合物。 D-变应原的最低浓度，在该浓度下，与血清混合后发生阳性点刺反应应为治疗前的最低浓度。积极的作用 。 -减少创伤。 G
展开▼
